Effects of neuromuscular electrical stimulation on glycemic control: a systematic review and meta-analysis.
NMES
e-stim
glucose
insulin sensitivity
metabolic health
muscle
myostimulation
substrate utilization
Journal
Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782
Informations de publication
Date de publication:
2023
2023
Historique:
received:
14
05
2023
accepted:
12
07
2023
medline:
17
8
2023
pubmed:
16
8
2023
entrez:
16
8
2023
Statut:
epublish
Résumé
Physical inactivity increases the risk for metabolic diseases such as obesity and type 2 diabetes. Neuromuscular electrical stimulation (NMES) is an effective method to induce muscle contraction, particularly for populations with physical impairments and/or metabolic diseases. However, its effectiveness to improve glycemic control is unclear. This review aimed to determine the effectiveness of NMES on glycemic control. Electronic search consisted of MEDLINE (PubMed), EMBASE, Cochrane Library, Google Scholar, and Web of Science to identify studies that investigated the effects of NMES on glycemic control for this systematic review. The meta-analysis consists of the studies designed as randomized controlled trials. Effect sizes were calculated as the standardized mean difference (SMD) and meta-analysis was conducted using a random-effects model. Thirty-five studies met the inclusion criteria for systematic review and of those, nine qualified for the meta-analysis. Existing evidence suggested that NMES effectively improves glycemic control predominantly in middle-aged and elderly population with type 2 diabetes, obesity, and spinal cord injury. The meta-analysis is comprised of 180 participants and reported that NMES intervention lowered fasting blood glucose (SMD: 0.48; 95% CI: 0.17 to 0.78; p=0.002; I²=0%). Additional analysis using the primary measures reported by each study to indicate glycemic control (i.e., OGTT, HOMA-IR, and fasting glucose) also confirmed a significant effect of NMES on improving glycemic control (SMD: 0.41; 95% CI, 0.09 to 0.72; p=0.01; I²=11%). NMES protocol varied across studies and requires standardization. NMES could be considered as a therapeutic strategy to improve glycemic control in populations with physical impairments and/or metabolic disorders. https://www.crd.york.ac.uk/prospero/, identifier CRD42020192491.
Sections du résumé
Background
Physical inactivity increases the risk for metabolic diseases such as obesity and type 2 diabetes. Neuromuscular electrical stimulation (NMES) is an effective method to induce muscle contraction, particularly for populations with physical impairments and/or metabolic diseases. However, its effectiveness to improve glycemic control is unclear. This review aimed to determine the effectiveness of NMES on glycemic control.
Methods
Electronic search consisted of MEDLINE (PubMed), EMBASE, Cochrane Library, Google Scholar, and Web of Science to identify studies that investigated the effects of NMES on glycemic control for this systematic review. The meta-analysis consists of the studies designed as randomized controlled trials. Effect sizes were calculated as the standardized mean difference (SMD) and meta-analysis was conducted using a random-effects model.
Results
Thirty-five studies met the inclusion criteria for systematic review and of those, nine qualified for the meta-analysis. Existing evidence suggested that NMES effectively improves glycemic control predominantly in middle-aged and elderly population with type 2 diabetes, obesity, and spinal cord injury. The meta-analysis is comprised of 180 participants and reported that NMES intervention lowered fasting blood glucose (SMD: 0.48; 95% CI: 0.17 to 0.78; p=0.002; I²=0%). Additional analysis using the primary measures reported by each study to indicate glycemic control (i.e., OGTT, HOMA-IR, and fasting glucose) also confirmed a significant effect of NMES on improving glycemic control (SMD: 0.41; 95% CI, 0.09 to 0.72; p=0.01; I²=11%). NMES protocol varied across studies and requires standardization.
Conclusion
NMES could be considered as a therapeutic strategy to improve glycemic control in populations with physical impairments and/or metabolic disorders.
Systematic review registration
https://www.crd.york.ac.uk/prospero/, identifier CRD42020192491.
Identifiants
pubmed: 37583429
doi: 10.3389/fendo.2023.1222532
pmc: PMC10424918
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, N.I.H., Extramural
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1222532Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK132430
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007592
Pays : United States
Informations de copyright
Copyright © 2023 Sanchez, Mossayebi, Sigaroodi, Apaflo, Galvan, Min, Agullo, Wagler and Bajpeyi.
Déclaration de conflit d'intérêts
Author FA was employed by the company Southwest Plastic Surgery. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Clin Interv Aging. 2016 Nov 18;11:1697-1706
pubmed: 27920508
J Neurol Neurosurg Psychiatry. 1968 Oct;31(5):415-23
pubmed: 5709825
Am J Physiol. 1996 Aug;271(2 Pt 2):R426-31
pubmed: 8770144
IEEE Trans Biomed Eng. 1984 Dec;31(12):752-63
pubmed: 6335484
BMJ. 2020 Jul 1;370:m2031
pubmed: 32611588
Am J Physiol. 1994 Feb;266(2 Pt 1):E186-92
pubmed: 8141276
Heart Vessels. 2021 Jun;36(6):844-852
pubmed: 33547929
J Physiol. 1973 Apr;230(2):359-70
pubmed: 4350770
Lancet. 2016 Sep 24;388(10051):1311-24
pubmed: 27475266
Eur J Appl Physiol Occup Physiol. 1999 Sep;80(4):373-8
pubmed: 10483809
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Acta Ortop Bras. 2018;26(5):346-349
pubmed: 30464720
Rev Med Chil. 2018 May;146(5):585-595
pubmed: 30148922
Metabolism. 2016 Jun;65(6):863-73
pubmed: 27173465
J Appl Physiol (1985). 1987 Jul;63(1):167-74
pubmed: 3624122
Phys Ther. 1990 Jul;70(7):416-22
pubmed: 2356218
Am J Physiol. 1991 Dec;261(6 Pt 1):E795-9
pubmed: 1662910
Arch Phys Med Rehabil. 2005 Jul;86(7):1502-4
pubmed: 16003691
Front Physiol. 2019 Mar 20;10:291
pubmed: 30949069
Eur J Appl Physiol Occup Physiol. 1999 Sep;80(4):394-6
pubmed: 10483812
Nature. 1985 Mar 14-20;314(6007):164-6
pubmed: 3974720
J Appl Physiol (1985). 2022 Jul 1;133(1):75-86
pubmed: 35608205
Mol Metab. 2020 Sep;39:100998
pubmed: 32305516
Phys Ther. 2008 Oct;88(10):1167-76
pubmed: 18703676
Eur J Appl Physiol Occup Physiol. 1996;74(4):311-7
pubmed: 8911822
Diabetes Res Clin Pract. 2012 Jun;96(3):306-12
pubmed: 22296854
Exerc Sport Sci Rev. 2007 Jul;35(3):102-9
pubmed: 17620928
BMC Musculoskelet Disord. 2021 Jun 22;22(1):569
pubmed: 34158031
Sports Med. 1992 May;13(5):320-36
pubmed: 1565927
Diabetes Technol Ther. 2015 Jun;17(6):413-9
pubmed: 25734937
Am J Physiol. 1990 Apr;258(4 Pt 1):E667-72
pubmed: 2159218
Eur J Transl Myol. 2017 Sep 20;27(3):6488
pubmed: 29118955
J Appl Physiol (1985). 1998 Oct;85(4):1218-22
pubmed: 9760308
J Neurophysiol. 1965 May;28:560-80
pubmed: 14328454
J Appl Physiol (1985). 2003 Jun;94(6):2107-12
pubmed: 12562670
Diabetes Res Clin Pract. 2018 Aug;142:37-45
pubmed: 29802953
Nutrients. 2021 Nov 29;13(12):
pubmed: 34959874
Arch Phys Med Rehabil. 2002 Jul;83(7):936-41
pubmed: 12098153
Am J Physiol. 1999 Dec;277(6):E1130-41
pubmed: 10600804
J Appl Physiol (1985). 2004 Mar;96(3):911-6
pubmed: 14594864
Endocr Connect. 2022 Feb 04;11(2):
pubmed: 35007207
Eur J Appl Physiol. 2011 Oct;111(10):2409-26
pubmed: 21805156
Muscle Nerve. 2007 May;35(5):562-90
pubmed: 17299744
J Physiol. 1998 Mar 1;507 ( Pt 2):593-602
pubmed: 9518716
Int J Obes. 1985;9(3):155-70
pubmed: 3840463
J Orthop Sports Phys Ther. 2003 Sep;33(9):492-501
pubmed: 14524508
Br J Sports Med. 2017 Nov;51(21):1540-1544
pubmed: 27044438
Physiol Rep. 2018 Aug;6(16):e13813
pubmed: 30156033
Am J Physiol Endocrinol Metab. 2012 Sep 1;303(5):E614-23
pubmed: 22739107
Med Sci Sports Exerc. 2001 Aug;33(8):1247-52
pubmed: 11474322
J Physiol. 1983 Dec;345:525-32
pubmed: 6663511
Am J Physiol. 1997 Oct;273(4):E688-94
pubmed: 9357796
Phys Ther. 2008 Nov;88(11):1297-321
pubmed: 18801852
Diabetes Metab J. 2015 Jun;39(3):264-7
pubmed: 26124997
Acta Diabetol. 2015 Apr;52(2):285-91
pubmed: 25107502
J Electromyogr Kinesiol. 2009 Aug;19(4):614-22
pubmed: 18440241
Exp Neurol. 1970 Apr;27(1):46-56
pubmed: 5439587
JAMA. 1999 Oct 27;282(16):1523-9
pubmed: 10546691
Chest. 2013 Feb 1;143(2):485-493
pubmed: 22911373
Appl Physiol Nutr Metab. 2019 Aug;44(8):834-839
pubmed: 30620614
J Appl Physiol (1985). 2013 Sep 1;115(5):756-64
pubmed: 23766505
Arch Phys Med Rehabil. 2010 Dec;91(12):1957-9
pubmed: 21112441
Can J Appl Physiol. 2003 Jun;28(3):424-33
pubmed: 12955869
Med Sci Sports Exerc. 2012 Jan;44(1):165-74
pubmed: 21659900
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Metabolism. 1999 Nov;48(11):1409-13
pubmed: 10582549
Diabetes Obes Metab. 2005 Jul;7(4):344-51
pubmed: 15955120
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5817-21
pubmed: 7597034
Muscle Nerve. 2017 May;55(5):669-675
pubmed: 27576602
Eur J Anaesthesiol. 2011 Jun;28(6):420-6
pubmed: 20962656
Diabetes. 1999 May;48(5):1192-7
pubmed: 10331428
Appl Physiol Nutr Metab. 2021 Aug 17;:1-7
pubmed: 34403626
J Electromyogr Kinesiol. 2015 Feb;25(1):136-42
pubmed: 25066515
Yale J Biol Med. 2012 Jun;85(2):201-15
pubmed: 22737049
PLoS One. 2012;7(3):e33203
pubmed: 22457744
Med Eng Phys. 2017 Jun;44:53-62
pubmed: 28363767
Int J Sports Med. 1999 Jul;20(5):279-83
pubmed: 10452223
Cell Biochem Funct. 2014 Dec;32(8):621-4
pubmed: 25529429
J Physiol. 1986 May;374:493-501
pubmed: 3746702
Spinal Cord. 2002 Mar;40(3):110-7
pubmed: 11859437
Exp Brain Res. 1997 Mar;114(1):117-23
pubmed: 9125456
Int J Sports Med. 1987 Aug;8(4):256-60
pubmed: 3667021
J Physiol. 2019 Jan;597(2):449-466
pubmed: 30414190